DGK-alpha helps cancer cells gain traction and mobilize

January 23, 2012
A new study in the Journal of Cell Biology reveals how a lipid-converting enzyme helps cancer cells gain traction and mobilize. In this image, Rab-coupling protein (green) gathers at the tip of the pseudopod of an invasive tumor cell. Credit: Elena Rainero

Metastasizing cancer cells often express integrins that provide better traction. A new study in The Journal of Cell Biology reveals how a lipid-converting enzyme helps the cells mobilize these integrins.

Adhesive integrin proteins continually cycle to and from the cell surface. cells that carry mutant forms of the often bias the process, increasing the recycling of a particular integrin that offers a better grip on the fibronectin fibers found in tumors. To make this change, mutant p53 requires the Rab-coupling protein (RCP), which connects the integrins to the Rab GTPases that promote membrane recycling. In turn, RCP links up with a lipid called phosphatidic acid.

A team of researchers led by Jim Norman found that diacylglycerol kinase alpha (DGK-alpha), an enzyme that makes phosphatidic acid, helps cancer cells to get moving. Tumor cells that were short on DGK-alpha didn't recycle the integrin and didn't penetrate into slabs of extracellular matrix.

In metastasizing tumor cells, vesicles sporting RCP are tethered to the tips of the advancing pseudopods. Few of these vesicles built up if DGK-alpha was absent, however, indicating that vesicle tethering requires phosphatidic acid. The researchers found that the particular tumor cells they studied didn't boost levels of DGK-alpha in order to metastasize. Instead, the team thinks that DGK-alpha permits to move following the acquisition of . By manufacturing lipid that binds to RCP, DGK-alpha enables the tumor cells to tether vesicles containing the integrins close to the plasma membrane, where the integrins can readily recycle.

Explore further: New drug targets for squamous cell carcinoma

More information: Rainero, E., et al. 2012. J. Cell Biol. doi: 10.1083/jcb.201109112

Related Stories

New drug targets for squamous cell carcinoma

May 19, 2011

Researchers at Fred Hutchinson Cancer Research Center have discovered a new drug target for squamous cell carcinoma – the second most common form of skin cancer. Scientists in the laboratory of Valeri Vasioukhin, Ph.D., ...

Recommended for you

Scientists block breast cancer cells from hiding in bones

May 25, 2016

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise ...

Genetic sequencing reveals drug resistance growth

May 25, 2016

The rate at which genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new research led by a Weill Cornell Medicine investigator. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.